feed,title,long_url,short_url
MarketWatch,"Eli Lilly, Vir and Glaxo say Phase 2 trial combining antibodies reduced viral load by 70% at day 7",http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/MnUcUYVj6p8/story.aspx,https://on.mktw.net/3sAiYiN
